Work

Malvidin-3-O-Glucoside and Its Gut-Derived Metabolites Reshape Focal Adhesion and Metabolomic Profiles in Human Enterocytes

Year: 2026
Type: article
Abstract: Background: Malvidin-3-O-glucoside (MV), a grape/berry anthocyanin, is metabolized in the gut to syringic acid (SA), gallic acid (GA), and pyrogallol. Despite reported antioxidative and anti-inflammatory activities, cell-specific actions in immune cells and enterocytes remain incompletely defined. Methods: We profiled human THP-1 monocytes, macrophages, and C2BBe1 enterocytes exposed to MV and metabolites using untargeted metabolomics. Functional readouts included cytokine/chemokine secretion, pathway enrichment, and lipid mediators with the endocannabinoid network. Benjamini–Hochberg false discovery rate (FDR) correction was applied; multivariate analyses were used in an exploratory capacity. Results: MV increased IL1B and IL8 in monocytes/macrophages while inhibiting CXCL10, CXCL11, and CXCL13; MV plus dimethyl fumarate suppressed CXCL10. In enterocytes, MV and its metabolic products altered focal adhesion–related pathways and histamine and were associated with changes in endocannabinoid-linked metabolites, such as N-arachidonoyl glycine and stearoyl ethanolamide; these observations derive from untargeted profiling without receptor, enzyme, or targeted validation. Conclusions: MV exerts cell type-dependent immunomodulatory effects, enhancing select cytokines while suppressing key chemokines. In enterocytes, MV is associated with transcriptional and metabolomic changes affecting focal adhesion pathways and endocannabinoid-related metabolites. These findings are hypothesis-generating and derived from in vitro models; receptor-level assays, orthogonal validation, and in vivo studies are required before inferring physiological modulation.
Source: Nutrients
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W7225886959
FWCI:
Cites:
Cited by:
Related to: 10